Brown JM - Search Results

1

The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Brown JM, Carlson DJ, Brenner DJ. Brown JM, et al. Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-62. doi: 10.1016/j.ijrobp.2013.07.022. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411596 Free PMC article. Review.

2

Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.

Carlson DJ, Keall PJ, Loo BW Jr, Chen ZJ, Brown JM. Carlson DJ, et al. Among authors: brown jm. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1188-95. doi: 10.1016/j.ijrobp.2010.10.007. Epub 2010 Dec 22. Int J Radiat Oncol Biol Phys. 2011. PMID: 21183291 Free PMC article.

3

Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al.

Brown JM, Carlson DJ, Brenner DJ. Brown JM, et al. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):693-4. doi: 10.1016/j.ijrobp.2014.03.014. Int J Radiat Oncol Biol Phys. 2014. PMID: 24929172 No abstract available.

4

High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patients.

Shuryak I, Carlson DJ, Brown JM, Brenner DJ. Shuryak I, et al. Among authors: brown jm. Radiother Oncol. 2015 Jun;115(3):327-34. doi: 10.1016/j.radonc.2015.05.013. Epub 2015 Jun 6. Radiother Oncol. 2015. PMID: 26058991 Free article.

5

In Regard to Song et al.

Brown JM, Carlson DJ. Brown JM, et al. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):251-252. doi: 10.1016/j.ijrobp.2020.06.075. Epub 2020 Nov 23. Int J Radiat Oncol Biol Phys. 2021. PMID: 33243481 No abstract available.

6

In Reply to Song et al, and In Reply to Brown and Carlson.

Grimm J, Mahadevan A, Brown JM, Carlson DJ, Brenner DJ, Lo SS, Song CW, Cho LC. Grimm J, et al. Among authors: brown jm. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):253-254. doi: 10.1016/j.ijrobp.2021.02.021. Int J Radiat Oncol Biol Phys. 2021. PMID: 33864825 No abstract available.

7

Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.

Brown JM, Brenner DJ, Carlson DJ. Brown JM, et al. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1159-60. doi: 10.1016/j.ijrobp.2012.11.003. Int J Radiat Oncol Biol Phys. 2013. PMID: 23517805 Free PMC article. No abstract available.

8

Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

Brown JM, Diehn M, Loo BW Jr. Brown JM, et al. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):323-7. doi: 10.1016/j.ijrobp.2010.04.070. Int J Radiat Oncol Biol Phys. 2010. PMID: 20832663 Free PMC article.

9

The Biology of SBRT: LQ or Something New?

Brown JM. Brown JM. Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):964. doi: 10.1016/j.ijrobp.2018.02.038. Epub 2018 Mar 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976509 No abstract available.

10

Radiation Damage to Tumor Vasculature Initiates a Program That Promotes Tumor Recurrences.

Brown JM. Brown JM. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):734-744. doi: 10.1016/j.ijrobp.2020.05.028. Epub 2020 May 28. Int J Radiat Oncol Biol Phys. 2020. PMID: 32473180 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,120 results

Search Page

Filters